On Monday, Roivant Sciences Ltd (NASDAQ: ROIV) was 1.34% up from the session before settling in for the closing price of $10.46. A 52-week range for ROIV has been $8.06 – $13.24.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 571.16% over the last five years. When this article was written, the company’s average yearly earnings per share was at 554.35%. With a float of $551.47 million, this company’s outstanding shares have now reached $760.14 million.
The firm has a total of 904 workers. Let’s measure their productivity.
Roivant Sciences Ltd (ROIV) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Roivant Sciences Ltd stocks. The insider ownership of Roivant Sciences Ltd is 31.57%, while institutional ownership is 50.51%. The most recent insider transaction that took place on Feb 09 ’24, was worth 1,058,694. In this transaction President & COO of this company sold 96,950 shares at a rate of $10.92, taking the stock ownership to the 532,207 shares. Before that another transaction happened on Jan 02 ’24, when Company’s 10% Owner sold 3,000,000 for $11.05, making the entire transaction worth $33,150,000. This insider now owns 51,929,426 shares in total.
Roivant Sciences Ltd (ROIV) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2023, it has been observed that the corporation posted -0.2 earnings per share (EPS) during the time that was better than consensus figure (set at -0.36) by 0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 554.35% per share during the next fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
You can see what Roivant Sciences Ltd (ROIV) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 27.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 69.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.21, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.19 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Analysing the last 5-days average volume posted by the [Roivant Sciences Ltd, ROIV], we can find that recorded value of 4.44 million was lower than the volume posted last year of 6.89 million. As of the previous 9 days, the stock’s Stochastic %D was 16.03%. Additionally, its Average True Range was 0.39.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 55.27%, which indicates a significant increase from 21.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.57% in the past 14 days, which was lower than the 38.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.94, while its 200-day Moving Average is $10.64. Now, the first resistance to watch is $10.82. This is followed by the second major resistance level at $11.05. The third major resistance level sits at $11.28. If the price goes on to break the first support level at $10.37, it is likely to go to the next support level at $10.14. Now, if the price goes above the second support level, the third support stands at $9.91.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
There are 805,846K outstanding shares of the company, which has a market capitalization of 8.54 billion. As of now, sales total 61,280 K while income totals -1,009 M. Its latest quarter income was 37,140 K while its last quarter net income were 5,096 M.
